Other Affiliated Sites
开元体育(中国)官方网站
开元体育·(中国)官方APP下载
开元体育平台(中国)官方网站app下载
开元体育官网(中国)官方下载-IOS/安卓通用版/手机APP下载
开云app(中国)官方网站-ios/安卓版/手机版app下载
开云·APP官方入口(中国)官方网站-IOS/安卓通用版/手机app
开云·APP(kaiyun)(中国)官方网站-IOS/Android通用版/手机app下载
华体会·(HTH)官网APP下载 - Apple app store
江南体育·(中国)官方网站 - ios/安卓版/手机APP下载
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Preparations Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
2021.06.08
H股公告
2021.06.07
THE GROUP’S ENOXAPARIN SODIUM INJECTION OBTAINS MARKETING APPROVAL FROM NATIONAL...
2021.06.04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3...
2021.06.02
关于控股子公司收到药物临床试验补充申请批准通知书的公告
2021.05.27
2020年年度股东大会决议公告
2021.05.27
2020年年度股东大会法律意见书
2021.05.26
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2021.05.26
POLL RESULTS OF THE 2020 ANNUAL GENERAL MEETING
2021.05.20
开元体育官网app手机版下载公开发行公司债券2021年跟踪评级报告
2021.05.19
关于孙暄先生增持公司H股计划的进展公告
第一页
上一页
15
16
17
18
19
下一页
最后一页
